Literature DB >> 10527006

Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma.

S A Oliveria1, P J Christos, A C Halpern, J A Fine, R L Barnhill, M Berwick.   

Abstract

We investigated the relationship between patient knowledge, awareness, and delay in seeking medical attention for melanoma. The study population was comprised of 255 cases with cutaneous melanoma newly diagnosed during January 15, 1987 to May 15, 1989, who were part of a population-based case control study. Personal interviews were conducted to obtain information on patient's knowledge of melanoma signs and symptoms, skin awareness, delay in seeking medical attention, and related covariates. The adjusted odds ratio for the association between skin awareness and delay was 0.30 (95% confidence interval 0.12-0.71). Odds ratios ranged from 0.43 to 0.81 for knowledge and delay. Awareness of skin changes was associated with a reduced Breslow depth for stage I melanomas. Individuals who are aware of skin changes and abnormalities appear to be less likely to delay seeking medical attention for melanoma. Knowledge of melanoma signs and symptoms may also contribute to a decreased delay in melanoma diagnosis.

Entities:  

Mesh:

Year:  1999        PMID: 10527006     DOI: 10.1016/s0895-4356(99)00083-9

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  13 in total

1.  Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin).

Authors:  Melody J Eide; Martin A Weinstock; Raymond G Dufresne; Suleka Neelagaru; Patricia Risica; Gary J Burkholder; David Upegui; Katharine A Phillips; Bruce K Armstrong; Leslie Robinson-Bostom
Journal:  J Invest Dermatol       Date:  2005-02       Impact factor: 8.551

2.  Skin Cancer: Have melanoma and skin cancer finally met their match?

Authors:  Jeffrey E Gershenwald; Kelly C Nelson
Journal:  Nat Rev Clin Oncol       Date:  2017-04-19       Impact factor: 66.675

3.  Sex Differences in Melanoma.

Authors:  Matthew Robert Schwartz; Li Luo; Marianne Berwick
Journal:  Curr Epidemiol Rep       Date:  2019-05-31

4.  Qualitative study of men's perceptions of why treatment delays occur in the UK for those with testicular cancer.

Authors:  Alison Chapple; Sue Ziebland; Ann McPherson
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

5.  Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011).

Authors:  Julie S Najita; Susan M Swetter; Alan C Geller; Jeffrey E Gershenwald; Marvin Zelen; Sandra J Lee
Journal:  J Invest Dermatol       Date:  2016-05-29       Impact factor: 8.551

6.  A systematic review and synthesis of qualitative and quantitative studies evaluating provider, patient, and health care system-related barriers to diagnostic skin cancer examinations.

Authors:  Maleka Najmi; Ashley E Brown; Sarah R Harrington; David Farris; Sarah Sepulveda; Kelly C Nelson
Journal:  Arch Dermatol Res       Date:  2021-04-28       Impact factor: 3.017

7.  Patient understanding of moles and skin cancer, and factors influencing presentation in primary care: a qualitative study.

Authors:  Fiona M Walter; Elka Humphrys; Simon Tso; Margaret Johnson; Simon Cohn
Journal:  BMC Fam Pract       Date:  2010-08-31       Impact factor: 2.497

8.  Do diagnostic delays in cancer matter?

Authors:  R D Neal
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

9.  Longitudinal, mixed method study to look at the experiences and knowledge of non melanoma skin cancer from diagnosis to one year.

Authors:  Fiona Bath-Hextall; Claire Jenkinson; Arun Kumar; Jo Leonardi-Bee; William Perkins; Karen Cox; Cris Glazebrook
Journal:  BMC Dermatol       Date:  2013-10-29

10.  Cancer awareness and socio-economic position: results from a population-based study in Denmark.

Authors:  Line Hvidberg; Anette Fischer Pedersen; Christian Nielsen Wulff; Peter Vedsted
Journal:  BMC Cancer       Date:  2014-08-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.